We are live on ! Find out more
ABP

Arthur B. Page Portfolio holdings

AUM $97.2M
1-Year Est. Return 25.76%
This Fund
S&P 500
This Quarter Est. Return
+4.61%
1 Year Est. Return
+25.76%
3 Year Est. Return
+40.44%
5 Year Est. Return
+103.47%
10 Year Est. Return
+251.6%
AUM
$107M
AUM Growth
+$3.11M
Cap. Flow
-$1.86M
Cap. Flow %
-1.74%
Top 10 Hldgs %
33.68%
Holding
83
New
2
Increased
31
Reduced
21
Closed
1

Top Buys

Rank Stock Value
1
XYL icon
Xylem
XYL
+$342K
2
ABBV icon
AbbVie
ABBV
+$312K
3
XLNX
Xilinx Inc
XLNX
+$241K
4
GSK icon
GSK
GSK
+$179K
5
JCI icon
Johnson Controls International
JCI
+$115K

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$1.09M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$972K
3
ABT icon
Abbott
ABT
+$339K
4
ILMN icon
Illumina
ILMN
+$221K
5
XOM icon
ExxonMobil
XOM
+$184K

Sector Composition

Rank Sector Weight
1 Healthcare 21.68%
2 Technology 20.65%
3 Industrials 15.41%
4 Miscellaneous 13.97%
5 Energy 11.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
51
AbbVie
ABBV
$464B
$335K 0.31%
+5,940
New +$312K
SJM icon
52
J.M. Smucker
SJM
$12.9B
$314K 0.29%
2,948
VWO icon
53
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$313K 0.29%
7,266
IWO icon
54
iShares Russell 2000 Growth ETF
IWO
$14.2B
$309K 0.29%
2,229
FDS icon
55
Factset
FDS
$9.99B
$301K 0.28%
2,505
IWN icon
56
iShares Russell 2000 Value ETF
IWN
$14.2B
$295K 0.28%
2,855
ABB
57
DELISTED
ABB Ltd
ABB
$292K 0.27%
12,700
-6,325
-33% -$153K
CL icon
58
Colgate-Palmolive
CL
$69.6B
$283K 0.26%
4,150
AMGN icon
59
Amgen
AMGN
$205B
$280K 0.26%
2,366
ICF icon
60
iShares Select U.S. REIT ETF
ICF
$1.96B
$252K 0.24%
5,764
ORCL icon
61
Oracle
ORCL
$410B
$240K 0.22%
5,920
CLX icon
62
Clorox
CLX
$10.6B
$219K 0.2%
2,399
T icon
63
AT&T
T
$184B
$218K 0.2%
8,157
MKC icon
64
McCormick & Company Non-Voting
MKC
$13.5B
$208K 0.19%
5,800
ILMN icon
65
Illumina
ILMN
$34.1B
-1,527
Closed -$221K

Similar funds

Arthur B. Page's Q2 2014 Portfolio in Review

As of Q2 2014, Arthur B. Page held 83 positions worth $107M, up 3% from $104M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 3.6%. Arthur B. Page opened 2 new positions and exited 1, leaving the 83-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.

  • Arthur B. Page's largest Q2 2014 buy was Xylem: 9,155 shares worth $358K.
  • Arthur B. Page added most to Xilinx Inc in Q2 2014, an estimated $241K increase.
  • Arthur B. Page's biggest Q2 2014 reduction was PepsiCo, cutting an estimated $1.09M.
  • Arthur B. Page fully exited Illumina in Q2 2014, selling an estimated $221K.
  • Arthur B. Page's ten largest holdings make up 34% of its $107M portfolio in Q2 2014.
  • Arthur B. Page opened 2 new positions and closed 1 in Q2 2014.
  • Arthur B. Page's portfolio value rose 3% quarter-over-quarter to $107M.

Based on Arthur B. Page's 13F filing for Q2 2014, filed 23 Jul 2014.